138 results
Page 3 of 7
8-K
EX-99.1
2y4x8wv
2 Dec 21
Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104
7:17am
8-K
EX-99.1
s4isj50
15 Nov 21
Acasti Pharma Announces Annual Stock Option Grants
12:00am
424B5
gak0ghsq u88vs7cy2
10 Nov 21
Prospectus supplement for primary offering
7:23am
8-K
EX-99.1
3x6sexe7
10 Nov 21
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022
7:09am
8-K
EX-99.1
zp2dhlb
22 Sep 21
Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing Standards
8:30am
8-K
EX-99.2
at5n9a9bxe6s0ups
27 Aug 21
Completion of Acquisition or Disposition of Assets
8:47am
425
EX-99.1
kzzzoxv9oj ypwsq9v
12 Aug 21
Business combination disclosure
11:00am
425
6zgyt9bxa3a3
12 Aug 21
Business combination disclosure
11:00am
8-K
skj70
12 Aug 21
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022
10:57am
8-K
EX-99.1
90re8fphpfh ik
12 Aug 21
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022
10:57am
425
atyvk
4 Aug 21
Business combination disclosure
5:03pm
425
h1j368a9
4 Aug 21
Business combination disclosure
5:00pm
8-K
EX-99.1
q3hihw0og1
23 Jul 21
Other Events
8:43am
8-K
70c8ib
23 Jul 21
Other Events
8:43am
425
EX-99.1
gtc0mgy4dkjmbzug9gr2
23 Jul 21
Business combination disclosure
8:41am
425
blh3v6o8t2h3sj gp
23 Jul 21
Business combination disclosure
8:41am
8-K
7lrt7n88b
21 Jul 21
Other Events
5:17pm